30.05.2016 • NewsElaine BurridgeBASFCoating Systems

BASF Sells Coating Systems Line to Colorcon

(c) BASF
(c) BASF

BASF is selling its Kollicoat IR Coating Systems product line to US-based Colorcon for an undisclosed sum. The sale, which is subject to approval by the Brazilian competition authorities, includes BASF’s current customer business, inventory and relevant knowhow.

Colorcon said the addition of Kollicoat complements its existing film coating portfolio and expands the options available to its customers. The company added that the acquisition would also further strengthen its existing activities with PVA-based pigmented, ready-to-use film coatings for use on immediate release forms of pharmaceuticals and dietary supplements.

Kelly Boyer, Colorcon’s general manager coatings, said the deal enabled both companies to focus on their core competences and further strengthened their existing cooperation which was announced in October 2014.

The companies said they look forward to expanding their cooperation by combining BASF’s polymer expertise with Colorcon’s formulation and application knowledge. BASF said it would focus on developing and promoting innovative film coating polymers including Kollicoat IR. The transfer of Kollicoat IR Coating Systems does not affect BASF’s Kollicoat IR polymer business.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.